Medicare Australia's performance under scrutiny



Medicare Australia, the agency the Federal Government has appointed to act as the superannuation clearing house for small employers, has received a critical analysis from the Australian National Audit Office (ANAO) regarding its handling of the Pharmaceutical Benefits Scheme (PBS).
An ANAO report, tabled in the Parliament yesterday, broadly endorsed Medicare’s administration of the PBS — but it also pointed to a number of deficiencies, including the accuracy of claims processing and performance. It also found that better operational guidance should be provided to key decision-makers.
The ANAO report has been tabled at a time when other, specialist superannuation clearing house operators have questioned the ability of Medicare to handle the task demanded of it by the Government.
Among the issues raised by the ANAO was its observation that Medicare Australia had adopted a practice “of adjusting Medicare Australia’s authority approval records to accord with the medicines actually dispensed in cases where there was a mismatch”.
The report said this practice carried with it the risk of failing to react to, or manage, evidence of incorrect dispensing of medicines.
It noted that Medicare had advised that it intends to address the issue through its nationally consistent quality control action plan, which it has recently endorsed.
Medicare has responded to the ANAO report by accepting the majority of its recommendations, some of which it said had been already implemented.
Recommended for you
With candidate retention a concern after a professional year, two large licensees have shared how they are structuring their programs to successfully ensure candidates are keen to remain beyond the year.
Evidentia Private has appointed PIMCO’s Haydn Scott as principal for private wealth solutions, focusing on asset consulting and private markets.
Financial advisers have been urged to consider the role they are using AT1 hybrids for in client portfolios when it comes to deciding on a suitable fixed income replacement, particularly for their retiree clients.
Private wealth manager Escala Partners has shared the difficult conversations that advisers need to have with their clients as strong sharemarkets prompt a portfolio rebalance.